Cardiovascular Diseases Clinical Trial
Official title:
Physical Therapy in Rehabilitation Program on Cardiovascular Diseases
INTRODUCTION: Cardiovascular diseases are the main causes of death in Brazil and in the world, associated with a large number of people with physical disabilities and disability, significantly burdening public health expenditures. Some patients end up having the need to do cardiac surgeries. , and consequently suffer complications associated with the surgical process due to prolonged rest in the bed, and complications are directly related to the morbidity and mortality rate in these patients. Thus, cardiac rehabilitation has great scientific evidences that directly impacts functional capacity, quality of life and thus reducing the morbimortality rate of these patients. However, it is worth noting that there is no outpatient cardiovascular rehabilitation service linked to the single health system (SUS) in the Amazon Region, that is, involving phase III of cardiac rehabilitation with defined and structured protocols for the group of patients already mentioned. OBJECTIVE: To analyze the clinical evolution of patients in the postoperative period of coronary artery bypass grafting and / or valve replacement (phase III), in outpatient treatment. METHODOLOGY: It is a a longitudinal study, with quantitative variables to be performed in a single center within a year (12 months). Which will evaluate the effects of phase III cardiac rehabilitation of patients undergoing cardiac surgery through an evaluation, which will evaluate heart rate variability, functional capacity by six-minute walk test, pulmonary volumes and capacities by spirometry, percutaneous strength and ventilatory muscle, MRC scale and manovacuometry, respectively, and the application of a quality of life assessment questionnaire. Subsequently, the protocol of 20 sessions will be applied and at the end the same variables will be re-evaluated. EXPECTED RESULTS: It is expected from the application of this research that the protocol suggested for the phase III cardiac rehabilitation of patients submitted to cardiac surgery will bring benefits to patients, such as improvement in heart rate variability, improvement in functional capacity, improvement in quality of life, and reduction in morbidity and mortality rates.
Characterized by the insufficiency of blood supply to the heart through the coronary
arteries, coronary artery disease (CAD) stands out as a global health problem, since it
represents the main cause of morbidity and mortality and is among the pathologies with the
greatest clinical and significantly increasing public health expenditures. In Brazil, it is
estimated that CAD corresponds to 80% of deaths due to cardiovascular diseases (CVD), mainly
in large centers and in the population with age over 40 years. CAD is associated with risk
factors such as systemic arterial hypertension, smoking, dyslipidemia, obesity, diabetes
mellitus, sedentary lifestyle, and in addition to the family history of coronary
insufficiency, that favors its onset.
The process of treatment of CAD is variable according to the level of involvement, and can be
performed through drugs, physical activities, nutritional control and surgical procedure.
Cardiac surgery is an alternative to promote improvement of cardiovascular function in
addition to reduction of morbimortality rates due to circulatory diseases, only performed
when clinical treatment is not able to provide cure and / or improvement of patient's quality
of life. Myocardial revascularization (CABG) surgery is one of the most accomplished cardiac
surgeries in Brazil, and it is currently recognized as a well-established procedure for the
treatment of CAD, since it is capable of prolonging and improving the quality of life of
these patients.
CABG aims at the resolution of myocardial ischemia, seeking the relief of symptoms and
consequently improvement of patient survival, biopsychosocial well-being, as well as the
earlier return to their daily activities, however, because it is an invasive procedure and
complexity, can imply several systemic repercussions such as cardiac, renal, infectious,
motor and pulmonary alterations. The postoperative complications of CABG depend on factors
related to the clinical situation at the time of surgery, such as age, life habits,
comorbidities, and also factors associated with the surgical process, such as duration of
surgery, use of extracorporeal circulation, schedules and the long-term invasive mechanical
ventilation and hospitalization.
Respiratory complications after CABG contribute to the reduction of the patients' quality of
life and increased morbimortality rates. Decreased respiratory muscle strength may be a
result of respiratory muscle injury during surgery and / or secondary to diaphragmatic
dysfunction due to phrenic nerve injury. Respiratory muscle weakness may compromise the
ventilation structure and function of these patients, exacerbating dyspnea, effort
intolerance, decreased ability to perform physical exercise, and consequently reduced
functional capacity (FC) of the individuals. The FC has a direct impact on the performance of
activities of daily living (ADLs), and in this context, the practice of physical exercise
after cardiac surgery is essential in the functional recovery of patients.
Cardiovascular rehabilitation (CVR) has a "1" level of recommendation and "A" grade of
scientific evidence, and physiotherapy has been the main component in this process, being
strongly associated with increased exercise capacity, improved dyspnea, quality of life, as
well as a decrease in mortality and morbidity rates, leading to an increase in the life
expectancy of these patients in the postoperative period .
Despite the well-known benefits of CVR, the number of patients participating in this program
is considered small, only 34% of the candidates are targeted and in the end, only 20% of
these candidates participate. In addition, as regards Phase IV rehabilitation, health
management of patients is still limited as improvements in lifestyle behavior are often not
maintained in the long run and levels of physical activity generally decline after a program
of successful outpatient rehabilitation, resulting in the loss of adaptations acquired as a
result of physical training.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|